{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:33:45Z","timestamp":1792528425406,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glioblastoma (GBM) acquires malignant traits through complex molecular adaptations that sustain immune evasion, often characterized by hypoxia and overexpression of the phagocytosis checkpoint CD47. However, the role of hypoxic drivers coordinating CD47-dependent immune evasion remains poorly defined. Here, we integrated single cell RNA sequencing and proteomic analysis to identify that insulin-like growth factor binding protein 2 (IGFBP2) was co-expressed with CD47 in hypoxic mesenchymal-like GBM subpopulations, synergistically promoting tumor progression and immune evasion. Mechanically, hypoxia induced IGFBP2 expression via HIF-2\u03b1-mediated transcriptional activation and further increased IGFBP2-positive exosome secretion through HIF-1\u03b1-dependent RAB3A upregulation. Moreover, IGFBP2 was predominantly localized on the exosome surface via integrin \u03b15\u03b21 and activated integrin\/FAK\/STAT3 signaling to enhance CD47 expression and inhibit macrophage phagocytosis. Clinically, serum exosomal IGFBP2 levels correlated with tumor grade and could serve as a diagnostic biomarker. Importantly, combinatorial blockade of IGFBP2 and CD47 synergistically suppressed tumor growth and prolonged survival in orthotopic GBM models. Together, our findings uncovered the hypoxia-exosomal IGFBP2-CD47 axis in GBM immune evasion and provided a compelling rationale for combination therapy to improve immunotherapy efficacy in GBM.<\/jats:p>","DOI":"10.1038\/s41419-026-08430-9","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:15:56Z","timestamp":1769847356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeting hypoxic exosomal IGFBP2 overcomes CD47-mediated immune evasion in glioblastoma"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5821-7550","authenticated-orcid":false,"given":"Yanhua","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huize","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingtong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6570-7208","authenticated-orcid":false,"given":"Haiquan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7787-9330","authenticated-orcid":false,"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7478-8898","authenticated-orcid":false,"given":"Hao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"8430_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41582-022-00679-w","volume":"18","author":"C Horbinski","year":"2022","unstructured":"Horbinski C, Berger T, Packer RJ, Wen PY. Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours. Nat Rev Neurol. 2022;18:515\u201329.","journal-title":"Nat Rev Neurol"},{"key":"8430_CR2","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S1474-4422(24)00160-1","volume":"23","author":"A Salvalaggio","year":"2024","unstructured":"Salvalaggio A, Pini L, Bertoldo A, Corbetta M. Glioblastoma and brain connectivity: the need for a paradigm shift. Lancet Neurol. 2024;23:740\u20138.","journal-title":"Lancet Neurol"},{"key":"8430_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.semcancer.2022.12.011","volume":"88","author":"C Liao","year":"2023","unstructured":"Liao C, Liu X, Zhang C, Zhang Q. Tumor hypoxia: from basic knowledge to therapeutic implications. Semin Cancer Biol. 2023;88:172\u201386.","journal-title":"Semin Cancer Biol"},{"key":"8430_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-023-00848-6","volume":"23","author":"X Yuan","year":"2024","unstructured":"Yuan X, Ruan W, Bobrow B, Carmeliet P, Eltzschig HK. Targeting hypoxia-inducible factors: therapeutic opportunities and challenges. Nat Rev Drug Discov. 2024;23:175\u2013200.","journal-title":"Nat Rev Drug Discov"},{"key":"8430_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54129-w","volume":"15","author":"TA Martins","year":"2024","unstructured":"Martins TA, Kaymak D, Tatari N, Gerster F, Hogan S, Ritz MF, et al. Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPgamma-derived CD47 blocker. Nat Commun. 2024;15:9718.","journal-title":"Nat Commun"},{"key":"8430_CR6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2321611121","volume":"121","author":"R Wu","year":"2024","unstructured":"Wu R, Sun C, Chen X, Yang R, Luan Y, Zhao X, et al. NSUN5\/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion. Proc Natl Acad Sci USA. 2024;121:e2321611121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8430_CR7","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/cns.13714","volume":"27","author":"H Wu","year":"2021","unstructured":"Wu H, Liu J, Wang Z, Yuan W, Chen L. Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma. CNS Neurosci Ther. 2021;27:1105\u201317.","journal-title":"CNS Neurosci Ther"},{"key":"8430_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40478-024-01740-z","volume":"12","author":"KG de Oliveira","year":"2024","unstructured":"de Oliveira KG, Bang-Rudenstam A, Beyer S, Boukredine A, Talbot H, Governa V, et al. Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche. Acta Neuropathol Commun. 2024;12:35.","journal-title":"Acta Neuropathol Commun"},{"key":"8430_CR9","doi-asserted-by":"crossref","unstructured":"Wang S, Huang T, Wu Q, Yuan H, Wu X, Yuan F, et al. Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation. J Clin Invest. 2024;134:e176851.","DOI":"10.1172\/JCI176851"},{"key":"8430_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm5214","volume":"387","author":"C Jackson","year":"2025","unstructured":"Jackson C, Cherry C, Bom S, Dykema AG, Wang R, Thompson E, et al. Distinct myeloid-derived suppressor cell populations in human glioblastoma. Science. 2025;387:eabm5214.","journal-title":"Science"},{"key":"8430_CR11","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","volume":"34","author":"D Guo","year":"2022","unstructured":"Guo D, Tong Y, Jiang X, Meng Y, Jiang H, Du L, et al. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IkappaBalpha. Cell Metab. 2022;34:1312\u201324 e6.","journal-title":"Cell Metab"},{"key":"8430_CR12","doi-asserted-by":"crossref","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.","DOI":"10.1126\/science.aau6977"},{"key":"8430_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01440-5","volume":"21","author":"G He","year":"2022","unstructured":"He G, Peng X, Wei S, Yang S, Li X, Huang M, et al. Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications. Mol Cancer. 2022;21:19.","journal-title":"Mol Cancer"},{"key":"8430_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12002","volume":"10","author":"N Bister","year":"2020","unstructured":"Bister N, Pistono C, Huremagic B, Jolkkonen J, Giugno R, Malm T. Hypoxia and extracellular vesicles: a review on methods, vesicular cargo and functions. J Extracell Vesicles. 2020;10:e12002.","journal-title":"J Extracell Vesicles"},{"key":"8430_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01450-4","volume":"22","author":"XJ Chen","year":"2024","unstructured":"Chen XJ, Guo CH, Wang ZC, Yang Y, Pan YH, Liang JY, et al. Hypoxia-induced ZEB1 promotes cervical cancer immune evasion by strengthening the CD47-SIRPalpha axis. Cell Commun Signal. 2024;22:15.","journal-title":"Cell Commun Signal"},{"key":"8430_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jhep.2022.03.011","volume":"77","author":"S Wang","year":"2022","unstructured":"Wang S, Wu Q, Chen T, Su R, Pan C, Qian J, et al. Blocking CD47 promotes antitumour immunity through CD103(+) dendritic cell-NK cell axis in murine hepatocellular carcinoma model. J Hepatol. 2022;77:467\u201378.","journal-title":"J Hepatol"},{"key":"8430_CR17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41388-019-0996-y","volume":"39","author":"M Qian","year":"2020","unstructured":"Qian M, Wang S, Guo X, Wang J, Zhang Z, Qiu W, et al. Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-kappaB pathways. Oncogene. 2020;39:428\u201342.","journal-title":"Oncogene"},{"key":"8430_CR18","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1016\/j.ymthe.2021.06.023","volume":"29","author":"W Qiu","year":"2021","unstructured":"Qiu W, Guo X, Li B, Wang J, Qi Y, Chen Z, et al. Exosomal miR-1246 from glioma patient body fluids drives the differentiation and activation of myeloid-derived suppressor cells. Mol Ther. 2021;29:3449\u201364.","journal-title":"Mol Ther"},{"key":"8430_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg1840","volume":"9","author":"JRW Conway","year":"2023","unstructured":"Conway JRW, Dinc DD, Follain G, Paavolainen O, Kaivola J, Bostrom P, et al. IGFBP2 secretion by mammary adipocytes limits breast cancer invasion. Sci Adv. 2023;9:eadg1840.","journal-title":"Sci Adv"},{"key":"8430_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06843-y","volume":"15","author":"H Lu","year":"2024","unstructured":"Lu H, Ai J, Zheng Y, Zhou W, Zhang L, Zhu J, et al. IGFBP2\/ITGA5 promotes gefitinib resistance via activating STAT3\/CXCL1 axis in non-small cell lung cancer. Cell Death Dis. 2024;15:447.","journal-title":"Cell Death Dis"},{"key":"8430_CR21","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/cac2.12420","volume":"43","author":"Z Wen","year":"2023","unstructured":"Wen Z, Sun H, Zhang Z, Zheng Y, Zheng S, Bin J, et al. High baseline tumor burden-associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2-STAT3-PD-L1 pathway. Cancer Commun (Lond). 2023;43:562\u201381.","journal-title":"Cancer Commun (Lond)"},{"key":"8430_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.canlet.2020.02.036","volume":"477","author":"T Li","year":"2020","unstructured":"Li T, Zhang C, Zhao G, Zhang X, Hao M, Hassan S, et al. IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma. Cancer Lett. 2020;477:19\u201330.","journal-title":"Cancer Lett"},{"key":"8430_CR23","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/ncb2574","volume":"14","author":"JC Gross","year":"2012","unstructured":"Gross JC, Chaudhary V, Bartscherer K, Boutros M. Active Wnt proteins are secreted on exosomes. Nat Cell Biol. 2012;14:1036\u201345.","journal-title":"Nat Cell Biol"},{"key":"8430_CR24","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1136\/gutjnl-2022-327998","volume":"72","author":"X Wang","year":"2023","unstructured":"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, et al. S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos. Gut. 2023;72:1370\u201384.","journal-title":"Gut"},{"key":"8430_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23946-8","volume":"12","author":"LG Lima","year":"2021","unstructured":"Lima LG, Ham S, Shin H, Chai EPZ, Lek ESH, Lobb RJ, et al. Tumor microenvironmental cytokines bound to cancer exosomes determine uptake by cytokine receptor-expressing cells and biodistribution. Nat Commun. 2021;12:3543.","journal-title":"Nat Commun"},{"key":"8430_CR26","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, et al. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell. 2019;178:835\u201349 e21.","journal-title":"Cell"},{"key":"8430_CR27","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41586-022-05688-9","volume":"614","author":"K Kamimoto","year":"2023","unstructured":"Kamimoto K, Stringa B, Hoffmann CM, Jindal K, Solnica-Krezel L, Morris SA. Dissecting cell identity via network inference and in silico gene perturbation. Nature. 2023;614:742\u201351.","journal-title":"Nature"},{"key":"8430_CR28","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.semcancer.2019.10.010","volume":"60","author":"TT Lah","year":"2020","unstructured":"Lah TT, Novak M, Breznik B. Brain malignancies: glioblastoma and brain metastases. Semin Cancer Biol. 2020;60:262\u201373.","journal-title":"Semin Cancer Biol"},{"key":"8430_CR29","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.7150\/thno.72248","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Han M, Wang S, Sun Y, Zhao W, Xue Z, et al. Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention. Theranostics. 2022;12:5451\u201369.","journal-title":"Theranostics"},{"key":"8430_CR30","first-page":"4071","volume":"46","author":"R Bjerkvig","year":"1986","unstructured":"Bjerkvig R, Laerum OD, Mella O. Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo. Cancer Res. 1986;46:4071\u20139.","journal-title":"Cancer Res"},{"key":"8430_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09720-x","volume":"10","author":"L Song","year":"2019","unstructured":"Song L, Tang S, Han X, Jiang Z, Dong L, Liu C, et al. KIBRA controls exosome secretion via inhibiting the proteasomal degradation of Rab27a. Nat Commun. 2019;10:1639.","journal-title":"Nat Commun"},{"key":"8430_CR32","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1073\/pnas.1120375109","volume":"109","author":"KM Holmes","year":"2012","unstructured":"Holmes KM, Annala M, Chua CY, Dunlap SM, Liu Y, Hugen N, et al. Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-kappaB network. Proc Natl Acad Sci USA. 2012;109:3475\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8430_CR33","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1038\/s41388-018-0525-4","volume":"38","author":"Y Liu","year":"2019","unstructured":"Liu Y, Li F, Yang YT, Xu XD, Chen JS, Chen TL, et al. IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma. Oncogene. 2019;38:1815\u201331.","journal-title":"Oncogene"},{"key":"8430_CR34","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.7150\/thno.94207","volume":"14","author":"X Jin","year":"2024","unstructured":"Jin X, Deng Q, Ye S, Liu S, Fu Y, Liu Y, et al. Cancer-associated fibroblast-derived periostin promotes papillary thyroid tumor growth through integrin-FAK-STAT3 signaling. Theranostics. 2024;14:3014\u201328.","journal-title":"Theranostics"},{"key":"8430_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216205","volume":"564","author":"J Lu","year":"2023","unstructured":"Lu J, Li J, Lin Z, Li H, Lou L, Ding W, et al. Reprogramming of TAMs via the STAT3\/CD47-SIRPalpha axis promotes acquired resistance to EGFR-TKIs in lung cancer. Cancer Lett. 2023;564:216205.","journal-title":"Cancer Lett"},{"key":"8430_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12146","volume":"10","author":"L Xi","year":"2021","unstructured":"Xi L, Peng M, Liu S, Liu Y, Wan X, Hou Y, et al. Hypoxia-stimulated ATM activation regulates autophagy-associated exosome release from cancer-associated fibroblasts to promote cancer cell invasion. J Extracell Vesicles. 2021;10:e12146.","journal-title":"J Extracell Vesicles"},{"key":"8430_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12310","volume":"12","author":"X Wang","year":"2023","unstructured":"Wang X, Wu R, Zhai P, Liu Z, Xia R, Zhang Z, et al. Hypoxia promotes EV secretion by impairing lysosomal homeostasis in HNSCC through negative regulation of ATP6V1A by HIF-1alpha. J Extracell Vesicles. 2023;12:e12310.","journal-title":"J Extracell Vesicles"},{"key":"8430_CR38","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/all.15744","volume":"78","author":"W Liao","year":"2023","unstructured":"Liao W, Chen G, Song L, Xu M, Li H, Wang Y, et al. Temperature regulates Rab3a and mast cell-derived exosomal FcepsilonRI to inhibit mast cell activation. Allergy. 2023;78:1707\u201310.","journal-title":"Allergy"},{"key":"8430_CR39","doi-asserted-by":"crossref","unstructured":"Martinez-Arroyo O, Flores-Chova A, Sanchez-Garcia B, Redon J, Cortes R, Ortega A. Rab3A\/Rab27A system silencing ameliorates high glucose-induced injury in podocytes. Biology (Basel). 2023;12:690.","DOI":"10.3390\/biology12050690"},{"key":"8430_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24167-9","volume":"12","author":"B Prasai","year":"2021","unstructured":"Prasai B, Haber GJ, Strub MP, Ahn R, Ciemniecki JA, Sochacki KA, et al. The nanoscale molecular morphology of docked exocytic dense-core vesicles in neuroendocrine cells. Nat Commun. 2021;12:3970.","journal-title":"Nat Commun"},{"key":"8430_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29137-3","volume":"13","author":"N Jiang","year":"2022","unstructured":"Jiang N, Xie B, Xiao W, Fan M, Xu S, Duan Y, et al. Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion. Nat Commun. 2022;13:1511.","journal-title":"Nat Commun"},{"key":"8430_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202206380","volume":"10","author":"L Du","year":"2023","unstructured":"Du L, Su Z, Wang S, Meng Y, Xiao F, Xu D, et al. EGFR-induced and c-Src-mediated CD47 phosphorylation inhibits TRIM21-dependent polyubiquitylation and degradation of CD47 to promote tumor immune evasion. Adv Sci (Weinh). 2023;10:e2206380.","journal-title":"Adv Sci (Weinh)"},{"key":"8430_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn9440","volume":"8","author":"T Shekarian","year":"2022","unstructured":"Shekarian T, Zinner CP, Bartoszek EM, Duchemin W, Wachnowicz AT, Hogan S, et al. Immunotherapy of glioblastoma explants induces interferon-gamma responses and spatial immune cell rearrangements in tumor center, but not periphery. Sci Adv. 2022;8:eabn9440.","journal-title":"Sci Adv"},{"key":"8430_CR44","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/j.immuni.2024.07.009","volume":"57","author":"R Kalluri","year":"2024","unstructured":"Kalluri R. The biology and function of extracellular vesicles in immune response and immunity. Immunity. 2024;57:1752\u201368.","journal-title":"Immunity"},{"key":"8430_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12234","volume":"11","author":"DX Zhang","year":"2022","unstructured":"Zhang DX, Dang XTT, Vu LT, Lim CMH, Yeo EYM, Lam BWS, et al. alphavbeta1 integrin is enriched in extracellular vesicles of metastatic breast cancer cells: a mechanism mediated by galectin-3. J Extracell Vesicles. 2022;11:e12234.","journal-title":"J Extracell Vesicles"},{"key":"8430_CR46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13045-020-00930-1","volume":"13","author":"E Eladl","year":"2020","unstructured":"Eladl E, Tremblay-LeMay R, Rastgoo N, Musani R, Chen W, Liu A, et al. Role of CD47 in hematological malignancies. J Hematol Oncol. 2020;13:96.","journal-title":"J Hematol Oncol"},{"key":"8430_CR47","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.blre.2018.04.005","volume":"32","author":"A Russ","year":"2018","unstructured":"Russ A, Hua AB, Montfort WR, Rahman B, Riaz IB, Khalid MU, et al. Blocking \u201cdon\u2019t eat me\u201d signal of CD47-SIRPalpha in hematological malignancies, an in-depth review. Blood Rev. 2018;32:480\u20139.","journal-title":"Blood Rev"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08430-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08430-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08430-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T15:04:01Z","timestamp":1770303841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08430-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8430"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08430-9","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"21 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal experiments were performed in accordance with Institutional Animal Care and Use Committee (IACUC) guidelines and were approved by the Animal Care and Use Committee of the Qilu Hospital of Shandong University (Approval No. DWLL-2023-169). All participants provided written informed consent, and the research was approved by the Ethical Committee on Scientific Research of Shandong University Qilu Hospital (approval number: KYLL-2022(ZM)-439).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval statement"}}],"article-number":"192"}}